Skip to content

Clinical trials

Multiple Myeloma trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Unknown status Clear all

345 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20024
20042
20058
20069
20073
20088
20098
201011
20116
20129
201317
201411
201512
20169
201715
201826
201930
202028
202138
202238
202325
202411

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status345

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital6
Shanghai Changzheng Hospital6
Hellenic Society of Hematology5
Institute of Hematology & Blood Diseases Hospital, China5
The First Affiliated Hospital of Soochow University5
Zhejiang University5
Assistance Publique - Hôpitaux de Paris4
Azienda Ospedaliera San Giovanni Battista4
Hebei Senlang Biotechnology Inc., Ltd.4
National University Hospital, Singapore4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma345
Neoplasms, Plasma Cell40
Lymphoma32
Recurrence27
Leukemia20
Lymphoma, Non-Hodgkin20
Hodgkin Disease17
Leukemia, Myeloid, Acute17
Precursor Cell Lymphoblastic Leukemia-Lymphoma17
Leukemia, Lymphocytic, Chronic, B-Cell16

Trials

Showing 26 to 50 of 345. Each trial links to its page on Pharma Observatory.

245 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.